Insider · CIK 0001813901
Bradley Herring
Files at OPLN (OPENLANE, Inc.), ENFN (Enfusion, Inc.). First filing Dec 26, 2024, latest Mar 7, 2025.
In brief
Bradley Herring files SEC Form 4 as CFO at ENFN (Enfusion, Inc.), and also at OPLN (OPENLANE, Inc.). Since Dec 26, 2024, Bradley Herring has reported 0 open-market buys worth $0 and 4 open-market sells worth $372k, the latest filed on Mar 7, 2025.
A track record needs three past buys with six months of prices behind them; Bradley Herring has 0, so none is measured yet.
The newest scored trade: sold $53k of ENFN on Mar 5, 2025, filed Mar 7, 2025, scored 44 (moderate).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 44Moderate | Enfusion, Inc. | $53k 4,645 shares | -1% | - | |
| 37Weak | Enfusion, Inc. | $18k 1,533 shares | -0% | - | |
| 43Moderate | Enfusion, Inc. | $42k 4,134 shares | -2% | - | |
| 35Weak | ENFNsell Enfusion, Inc. | $259k 24,443 shares | -8% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 5, 2025 | ENFN Enfusion, Inc. | 4,645 0.00% of outstanding | $53k | Mar 5, 2025 | $319k |
| Mar 3, 2025 | ENFN Enfusion, Inc. | 1,533 0.00% of outstanding | $18k | Mar 3, 2025 | $301k |
| Jan 7, 2025 | ENFN Enfusion, Inc. | 4,134 0.00% of outstanding | $42k | Jan 7, 2025 | $259k |
| Dec 20, 2024 | ENFN Enfusion, Inc. | 24,443 0.03% of outstanding | $259k | Dec 20, 2024 | none |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 27, 2026 | OPLN OPENLANE, Inc. | MOption exercise Common Stock | +16,190 | $0.00 | $0 | 16,190 | May 28, 2026 |
| May 27, 2026 | OPLN OPENLANE, Inc. | FTax withholding Common Stock | -4,453 | $36.90 | $164k | 11,737 | May 28, 2026 |
| May 27, 2026 | OPLN OPENLANE, Inc. | MOption exercise Restricted Stock Unitsderivative | -16,190 | $0.00 | $0 | 32,382 | May 28, 2026 |
| Feb 19, 2026 | OPLN OPENLANE, Inc. | AGrant or award Restricted Stock Unitsderivative | +42,721 | $0.00 | $0 | 42,721 | Feb 20, 2026 |
| May 27, 2025 | OPLN OPENLANE, Inc. | AGrant or award Restricted Stock Unitsderivative | +48,572 | $0.00 | $0 | 48,572 | May 28, 2025 |
| Apr 21, 2025 | ENFN Enfusion, Inc. | DDisposition to issuer Class A Common Stock | -108,332 | - | - | 216,357 | Apr 21, 2025 |
| Apr 21, 2025 | ENFN Enfusion, Inc. | DDisposition to issuer Class A Common Stock | -216,357 | - | - | 0 | Apr 21, 2025 |
| Mar 5, 2025 | ENFN Enfusion, Inc. | SOpen-market sale Class A Common Stock | -4,645 | $11.38 | $53k | 324,689 | Mar 7, 2025 |
| Mar 3, 2025 | ENFN Enfusion, Inc. | SOpen-market sale Class A Common Stock | -1,533 | $11.48 | $18k | 329,334 | Mar 5, 2025 |
| Feb 26, 2025 | ENFN Enfusion, Inc. | AGrant or award Class A Common Stock | +58,202 | $0.00 | $0 | 324,571 | Feb 28, 2025 |
| Feb 26, 2025 | ENFN Enfusion, Inc. | AGrant or award Class A Common Stock | +6,296 | $0.00 | $0 | 330,867 | Feb 28, 2025 |
| Jan 7, 2025 | ENFN Enfusion, Inc. | SOpen-market sale Class A Common Stock | -4,134 | $10.13 | $42k | 266,369 | Jan 10, 2025 |
| Dec 20, 2024 | ENFN Enfusion, Inc. | SOpen-market sale Class A Common Stock | -24,443 | $10.61 | $259k | 270,503 | Dec 26, 2024 |
Questions about Bradley Herring
Answered from the filings on this page, as of the latest one.
Is Bradley Herring buying or selling?
Not in the last 12 months. Bradley Herring's latest open-market trade on SEC Form 4 was sold $53k of ENFN on Mar 5, 2025.
How did Bradley Herring's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Bradley Herring has 0.
Where does Bradley Herring file Form 4?
Bradley Herring has filed Form 4 at ENFN (Enfusion, Inc.) as Chief Financial Officer; OPLN (OPENLANE, Inc.) as EVP & CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.